Thomas Krivak, MD
Gynecologic Oncology · Pittsburgh, PANPI 1609840057
Payments from drug & device makers
Across 1,388 payments — averaging $4371.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tesaro, Inc.$2.9M
- AbbVie$861K
- AstraZeneca$655K
- Merck$375K
- GSK$334K
- Medtronic$294K
- plus $619K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tesaro, Inc. | 169 | $2,930,763 |
| AbbVie | 58 | $860,638 |
| AstraZeneca | 445 | $654,607 |
| Merck | 127 | $374,895 |
| GSK | 213 | $334,080 |
| Medtronic | 30 | $294,009 |
| Genentech, Inc. | 28 | $130,377 |
| Novocure Inc. | 22 | $117,560 |
| Genmab U.S., Inc. | 68 | $104,413 |
| Pfizer | 35 | $50,884 |
| Seagen Inc. | 31 | $37,452 |
| Myriad Genetic Laboratories, Inc. | 41 | $34,301 |
| Immunogen, Inc. | 22 | $33,191 |
| Verastem, Inc. | 5 | $32,074 |
| Genentech USA, Inc. | 8 | $21,522 |
| Daiichi Sankyo Inc. | 13 | $20,903 |
| Eisai Inc. | 11 | $13,347 |
| Clovis Oncology, Inc. | 24 | $11,638 |
| Biom'up SA | 12 | $6,987 |
| Biontech SE | 2 | $2,160 |
| Karyopharm Therapeutics Inc. | 5 | $874 |
| Coopersurgical, Inc. | 5 | $513 |
| Caris MPI, Inc. | 6 | $329 |
| Stryker | 3 | $310 |
| Corcept Therapeutics | 2 | $252 |
| Foundation Medicine, Inc. | 1 | $105 |
| Regeneron | 1 | $81 |
| Roche Diagnostics Corporation | 1 | $15 |
How this compares
$6,068,280 in reported general payments places this provider in the 95th percentile of 90 gynecologic oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Pittsburgh
- Alexander OlawaiyePittsburgh$4.1M
- Eirwen MillerPittsburgh$2.6M
- Sarah CraftonPittsburgh$2.5M
- John NakayamaPittsburgh$349K
- Joseph KelleyPittsburgh$12K
- Jessica BergerPittsburgh$4K
- Madeleine Courtney-BrooksPittsburgh$2K
- Alison GarrettPittsburgh$2K
- Christopher MorsePittsburgh$2K
- Mackenzy RadolecPittsburgh$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.